XRCC3 C18067T Polymorphism Contributes a Decreased Risk to Both Basal Cell Carcinoma and Squamous Cell Carcinoma: Evidence from a Meta-Analysis
Figure 5
Forest plots of XRCC3 C18067T polymorphisms and skin cancer risk which is stratified by cutaneous melanoma, basal cell carcinoma and squamous cell carcinoma (recessive model TT versus . TC/CC).